v3.20.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating Activities:    
Net income $ 421,407 $ 461,366
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and impairment expense 122,074 124,401
Gain on sale and retirement of assets (13,187) (26,437)
Earnings of non-controlled entities (77,349) (72,040)
Distributions from operations of non-controlled entities 102,699 83,069
Equity-based incentive compensation expense 4,411 15,804
Settlement gain, amortization of prior service credit and actuarial loss 2,526 4,943
Debt prepayment costs 12,893 8,270
Changes in operating assets and liabilities:    
Trade accounts receivable and other accounts receivable 33,394 (35,757)
Inventory 66,776 12,828
Accounts payable 12,312 22,110
Accrued payroll and benefits (34,937) (22,880)
Accrued interest payable (8,731) (5,453)
Accrued taxes other than income (12,522) (4,945)
Accrued product liabilities (37,898) 977
Deferred revenue (3,984) (9,189)
Other current and noncurrent assets and liabilities (26,631) 13,493
Net cash provided by operating activities 563,253 570,560
Investing Activities:    
Additions to property, plant and equipment, net (292,217) (487,662)
Proceeds from sale and disposition of assets 332,872 63,887
Investments in non-controlled entities (59,458) (112,251)
Distributions from returns of investments in non-controlled entities 0 7,500
Deposits received from undivided joint interest third party 0 26,352
Net cash used by investing activities (18,803) (502,174)
Financing Activities:    
Distributions paid (466,019) (457,377)
Net commercial paper borrowings 141,000 197,000
Borrowings under long-term notes 499,400 496,855
Payments on notes (550,000) (550,000)
Debt placement costs (4,255) (6,817)
Net payment on financial derivatives (10,444) (8,028)
Payments associated with settlement of equity-based incentive compensation (14,700) (9,764)
Debt prepayment costs (12,893) (8,270)
Repurchases of common units 201,982 0
Net cash used by financing activities (619,893) (346,401)
Change in cash, cash equivalents and restricted cash (75,443) (278,015)
Cash, cash equivalents and restricted cash at beginning of period 84,599 309,261
Cash, cash equivalents and restricted cash at end of period 9,156 31,246
Supplemental non-cash investing activities:    
Additions to property, plant and equipment (235,587) (514,812)
Changes in accounts payable and other current liabilities related to capital expenditures (56,630) 27,150
Additions to property, plant and equipment, net $ (292,217) $ (487,662)